A sweeping effort by Merck  Co to revive a livestock drug it pulled from the US market last year is stalling amid resistance from the nations largest beef processors Merck for months has been preparing to conduct a largescale study this summer to demonstrate the safety of its Zilmax product The feed additive was widely used to promote weight gain in US cattle before Merck suspended sales in August  because of concerns in the beef industry that the drug made it difficult for some animals to walk